Looking to sell Twin stock or options?
Twin has developed a precision health platform aimed at diagnosing and repairing metabolic issues in diabetic patients. The platform leverages artificial intelligence, the internet of things, and digital technologies to identify metabolic dysfunction. By combining data, employing a unique digital twin AI technology, and utilizing insights from a clinical care team, Twin creates a comprehensive understanding of each patient's metabolism. This approach allows for the targeted repair of metabolic damage, which is the primary cause of diabetes, enabling healthcare professionals to craft personalized treatment plans for diabetic patients.
Corner Ventures, Peak XV Partners, Temasek Holdings, Helena Special Investments, Benchmark Capital Holdings, Sequoia Capital, Tru Arrow Partners, Sofina, DAG Ventures, ICONIQ Growth, Able Partners, G9 Ventures, LTS Investments, Next Play Ventures, Perceptive Advisors.